Growth Metrics

CareDx (CDNA) Cash from Financing Activities (2016 - 2026)

CareDx's Cash from Financing Activities history spans 14 years, with the latest figure at -$2.9 million for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities fell 352.72% to -$2.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$95.7 million, a 1823.24% decrease, with the full-year FY2025 number at -$93.4 million, down 1565.97% from a year prior.
  • Cash from Financing Activities hit -$2.9 million in Q1 2026 for CareDx, up from -$12.5 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for CDNA hit a ceiling of $1.4 million in Q3 2024 and a floor of -$53.8 million in Q2 2025.
  • Historically, Cash from Financing Activities has averaged -$8.0 million across 5 years, with a median of -$1.6 million in 2023.
  • Biggest five-year swings in Cash from Financing Activities: skyrocketed 5788.0% in 2024 and later plummeted 1962.03% in 2025.
  • Tracing CDNA's Cash from Financing Activities over 5 years: stood at -$2.4 million in 2022, then plummeted by 1033.09% to -$26.9 million in 2023, then soared by 96.64% to -$903000.0 in 2024, then plummeted by 1280.07% to -$12.5 million in 2025, then soared by 76.64% to -$2.9 million in 2026.
  • Business Quant data shows Cash from Financing Activities for CDNA at -$2.9 million in Q1 2026, -$12.5 million in Q4 2025, and -$26.5 million in Q3 2025.